EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
EAHP EU Monitor – 20th July 2012
The 6 month Cypriot Presidency of the Council of Ministers has outlined 7 health policy priorities including Clinical Trials, Pharmacovigilance and Medical Device regulation
A newly published web page of the Cyprus Presidency lists 7 priorities for health:
1. Healthy ageing across the lifecycle
2. A legislative proposal on serious cross border threats to health
3. Organ donation and transplantation
4. Pharmacovigilance
5. Clinical Trials
6. Transparency of measures regulating the pricing of medicinal products for human use
7. Medical Device regulation
On health ageing the Cyprus Presidency will “further develop work in the area of healthy ageing by collecting evidence and highlighting best practices which prove that Healthy Ageing is a matter of continuous process that requires the implementation of health promotion and disease prevention programmes. In this effort, key elements will be, among others, the multidisciplinary approaches involving both individuals and their community, and their application throughout the lifecycle, from early stages of life until the late years.”
On Cross Border health threats, the Cyprus Presidency will advance National Government’s discussions on the Commission’s December 2011 legislative proposal on the subject, and promote “the regional dimension of health security and capacity building”.
On Organ Donation and Transplantation, the Cyprus Presidency will highlight the need for coordinated member state activity to address the shortage of human organs intended for transplantation and aim to move forward “the establishment of coordination and cooperation mechanism among member states”.
On Pharmacovigilance and Clinical Trials, the Presidency will respectively help to oversee the implementation of the 2010 Pharmacovigilance Directive, and the beginning of Member State scrutiny of the Commission’s July 2012 proposals for reform of Clinical Trial governance.
On transparency of medicines reimbursement, the Cyprus Presidency will continue the work of the Danish Presidency in replacing the 1989 Directive on this subject with the aim of further increasing transparency of decisions made by Member States on reimbursement.
Finally, in relation to Medical Devices, the Presidency will initiate Member State level discussions on a forthcoming proposal from the Commission for reform of regulation in relation to Devices, including in areas of assessment and traceability
More information here
